Nicotinamide riboside, or NR, is a vitamin B3-related molecule your body can use to make NAD+, a coenzyme needed for energy metabolism and many other cellular reactions. Human studies show that oral NR, usually studied as nicotinamide riboside chloride, reaches NAD+ metabolism and can raise measured NAD+ or related metabolites in blood.[1][4][5]
For a woman in midlife, the useful first step is simply knowing which molecule you are looking at. NR, NAD+, NMN, niacin and nicotinamide share parts of the same biology, but they are different compounds with different human studies behind them.
NR became popular because it provides another route into the pathways that make NAD+. That makes its biology interesting. It also makes the label language easy to confuse.
The clearest way to understand NR is to separate three questions: what the molecule is, how it enters NAD+ metabolism, and what researchers have actually measured after people take it.
Where does nicotinamide riboside fit in the vitamin B3 family?
The National Institutes of Health includes nicotinamide riboside among the vitamin B3-related forms and derivatives grouped under niacin. Your tissues use vitamin B3 chemistry to build NAD+, which then participates in hundreds of enzyme reactions.[1]
NR is a nucleoside made from nicotinamide joined to a ribose sugar. In the familiar cellular pathway, nicotinamide riboside kinases convert NR to nicotinamide mononucleotide, or NMN. NMN can then be converted to NAD+.[2]
This relationship explains why NR is called an NAD+ precursor. A precursor is a molecule the body can use as material in a pathway that produces another molecule.
NR, NR chloride and NIAGEN: how to read the names
The front of a bottle may say “NR,” while the supplement facts panel or a clinical paper says “nicotinamide riboside chloride.” The distinction matters, but it is easier than it sounds.
CELLSHE TOOL
NR Label and Study Reading Sheet
| Term | What it means | Why it matters |
|---|---|---|
| NR | Nicotinamide riboside, the active vitamin B3-related NAD+ precursor. | This is the molecule discussed in NR research. |
| NR chloride / NRCl | The chloride salt form of nicotinamide riboside used in dietary-supplement ingredients. | USP has a dedicated nicotinamide riboside chloride monograph, and much of the published oral human evidence used this form.[3][4][5][6] |
| NIAGEN | A branded nicotinamide riboside chloride ingredient used in several human trials. | It is a brand of NR chloride, not a separate NAD+ precursor. Product-specific questions belong in our Tru Niagen review. |
| NAD+ | The coenzyme NR ultimately feeds into through NAD+ biosynthesis. | NAD+ is the target molecule, while NR is one precursor route. |
| NMN | Nicotinamide mononucleotide, another NAD+ precursor and an intermediate between NR and NAD+ in the classic cellular pathway. | Pathway position alone does not establish which oral precursor produces better health outcomes. |
| Nicotinamide / niacinamide | Another vitamin B3 form that also contributes to NAD+ metabolism. | It has different pharmacology and should not be treated as another name for NR.[1][7] |
Five checks before you interpret an NR study
- Form: Was the intervention NR, NR chloride, a branded ingredient, or another NAD+ compound?
- Population: Healthy adults, postmenopausal women, people with obesity, sarcopenia, or another clinical group?
- Study exposure: What dose was tested, and for how long?
- Biological sample: Whole blood, PBMCs, plasma, muscle, or another tissue?
- Endpoint: NAD+ biology, a functional outcome, a symptom, or a clinical measure?
My question:
CELLSHE synthesis based on NIH vitamin B3 terminology, the USP nicotinamide riboside chloride monograph, and the human NR studies cited below.[1][3][4][5][6]
How does NR become part of NAD+ metabolism?
CELLSHE ANALYSIS
The simple cellular pathway
The pathway diagram is useful for learning the chemistry. It is a poor shortcut for ranking supplements.
A 2026 human study compared NR, NMN and nicotinamide directly. After 14 days, 1,000 mg/day of NR and 1,000 mg/day of NMN produced comparable sustained increases in whole-blood NAD+. The study also linked oral precursor metabolism with gut microbial pathways.[7]
That is why our NMN vs NR comparison uses human outcomes and target engagement rather than arguing that one molecule wins because it sits one biochemical step closer to NAD+. Explore the full NMN evidence in our NMN for Women guide.
What happens in human studies after people take NR?
The most reproducible human finding is target engagement: oral NR changes the NAD+ metabolome and can raise measured NAD+ in blood. That result has appeared across acute pharmacokinetic work and longer randomized trials.[4][5][6]
CELLSHE EVIDENCE MAP
Three human studies that establish the NR biology
| Study | Who and what was tested | Measured result | Best use of the finding |
|---|---|---|---|
| Trammell et al., 2016 | 12 healthy adults, ages 30 to 55. Single oral NR chloride doses of 100, 300 and 1,000 mg in a randomized crossover pharmacokinetic study. | NR produced dose-related changes across the PBMC NAD+ metabolome, including higher NAD+ and NAAD measures.[4] | Shows that oral NR reaches human NAD+ metabolism after a single dose. |
| Martens et al., 2018 | 30 healthy adults ages 55 to 79 were randomized, and 24 completed both study periods. The cohort included postmenopausal women. NR chloride was given at 500 mg twice daily for 6 weeks in a randomized double-blind crossover trial. | Blood cellular NAD+ metabolism increased, and the intervention was well tolerated over the study period.[5] | Extends target engagement into healthy middle-aged and older adults. |
| Conze et al., 2019 | 140 healthy adults with overweight. NR chloride at 100, 300 or 1,000 mg/day for 8 weeks versus placebo. | Whole-blood NAD+ rose 22%, 51% and 142% across the three NR groups within 2 weeks, with increases maintained through the study.[6] | Shows a dose-related whole-blood biomarker response over 8 weeks. |
Study context: the 2016 pharmacokinetic study was sponsored by ChromaDex and included investigators with company ties. The 2019 trial was funded by ChromaDex, with two authors employed by the company. The 2018 Martens trial declared no competing interests, while ChromaDex supplied the study pills and NR standards and provided partial funding.[4][5][6]
These studies answer an important biochemical question well. They show that oral NR can engage human NAD+ metabolism. The next question, whether that translates into a meaningful change in muscle function, metabolism, cognition, cardiovascular health or another outcome, depends on the population and endpoint. A 2025 review of the human NAD+ precursor literature reached the same broader conclusion: target engagement is established more clearly than universal clinical benefit.[8]
For the endpoint-by-endpoint evidence, use the NR Benefits page rather than turning this definition article into a second benefits review.
What should women in midlife understand about NR and age?
Your age alone does not tell you that your whole-blood NAD+ is low. In 2026, researchers measured whole-blood NAD+ across seven human cohorts and found it remained remarkably stable with age, even though it responded to NR supplementation.[9]
Other tissues and clinical states can tell a different story. A 2019 study found lower NAD+ levels and impaired NAD+ biosynthesis in skeletal muscle from 119 older men with sarcopenia compared with age-matched controls across three populations.[10]
CELLSHE interpretation: human NAD+ biology is tissue- and context-dependent. Whole-blood NAD+ should not be treated as a simple countdown with every birthday, while disease-related muscle findings should stay attached to the population that was studied.
Our NAD+ Levels by Age article maps the human blood, muscle, brain and other tissue evidence in detail.
How is NR different from NMN and direct NAD+?
NR and NMN are different precursors that can both raise circulating NAD+ in humans. The 2026 direct comparison found similar sustained whole-blood NAD+ responses after 14 days at the tested 1,000 mg/day doses.[7] The fuller decision belongs in our NMN vs NR guide, while NR vs NMN vs Niacin covers the broader precursor family.
Direct NAD+ is a separate category, and the evidence changed in 2026. A randomized five-day study of one modified oral NAD+ formulation reported an increase in intracellular whole-blood NAD+ without increasing plasma NAD+.[11] That finding belongs to the tested formulation, but it means the old blanket statement that people cannot take NAD+ directly is obsolete.
If route and formulation are the question, our NAD+ IV vs oral guide keeps direct NAD+, injections and precursor evidence separate.
The useful definition to keep: nicotinamide riboside is a vitamin B3-related NAD+ precursor with repeated human evidence for engaging NAD+ metabolism. “NR,” “NR chloride,” “NMN” and “NAD+” should not be used as interchangeable names.
What is nicotinamide riboside, in practical terms?
NR is best understood as a well-studied input into NAD+ biology. Human trials show that oral NR can raise or reshape NAD+ measures in blood, including in middle-aged and older adults. That gives the molecule a clear biological role.
For a woman in midlife, start with the outcome you care about, then read the study that measured that outcome in the right population. The label tells you the molecule. The study design tells you what that molecule has actually shown.
Scientific references
- National Institutes of Health, Office of Dietary Supplements. Niacin: Fact Sheet for Health Professionals. Accessed September 23, 2026. NIH ODS.
- National Cancer Institute. Nicotinamide riboside. NCI Drug Dictionary. Accessed September 23, 2026. NCI.
- United States Pharmacopeia. Nicotinamide Riboside Chloride. USP-NF Dietary Supplement Monographs. 2026. DOI: 10.31003/USPNF_M17715_02_01. USP.
- Trammell SAJ, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. 2016;7:12948. PMID: 27721479. DOI: 10.1038/ncomms12948. PubMed.
- Martens CR, Denman BA, Mazzo MR, et al. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications. 2018;9:1286. PMID: 29599478. DOI: 10.1038/s41467-018-03421-7. PubMed.
- Conze D, Brenner C, Kruger CL. Safety and Metabolism of Long-term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-controlled Clinical Trial of Healthy Overweight Adults. Scientific Reports. 2019;9:9772. PMID: 31278280. DOI: 10.1038/s41598-019-46120-z. PubMed.
- Christen S, Redeuil K, Goulet L, et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism. 2026;8:62-73. PMID: 41540253. DOI: 10.1038/s42255-025-01421-8. PubMed.
- Vinten KT, Trętowicz MM, Coskun E, et al. NAD+ precursor supplementation in human ageing: clinical evidence and challenges. Nature Metabolism. 2025;7:1974-1990. PMID: 41083806. DOI: 10.1038/s42255-025-01387-7. PubMed.
- Trętowicz MM, Scantlebery AML, Schomakers BV, et al. Human whole-blood NAD+ levels do not vary with age or lifestyle interventions. Nature Metabolism. 2026;8:1282-1290. PMID: 42135539. DOI: 10.1038/s42255-026-01537-5. PubMed.
- Migliavacca E, Tay SKH, Patel HP, et al. Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities. Nature Communications. 2019;10:5808. PMID: 31862890. DOI: 10.1038/s41467-019-13694-1. PubMed.
- Kornilov SA, Hastings WJ, McGrath LF, et al. Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. GeroScience. 2026. PMID: 42530810. DOI: 10.1007/s11357-026-02399-1. PubMed.
